Dr. Linda Shore-Lesserson, in her prospective study of cardiac surgery, showed a reduction in postoperative transfusion incidence of non-RBC blood products from 25% in the standard coagulation test-guided group to 5.6% in the TEG®-guided group.

<< Back | Next >>


For further assistance, call 1-800-GET-A-TEG / 1-847-588-0453
Haemonetics Corp. | Sales Contacts | Contact Us | Feedback | Events
COPYRIGHT © 1998-2007 Haemoscope Corporation. All rights reserved.